Literature DB >> 4194998

Recurrence of hyperthyroidism shortly after return of normal suppressibility by triiodothyronine.

J A Wils, P W Kloppenborg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4194998      PMCID： PMC1701512          DOI： 10.1136/bmj.3.5718.327

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  5 in total

1.  USE OF A THYROID SUPPRESSION TEST AS A GUIDE TO PROGNOSIS OF HYPERTHYROIDISM TREATED WITH ANTITHYROID DRUGS.

Authors:  C E CASSIDY
Journal:  J Clin Endocrinol Metab       Date:  1965-02       Impact factor: 5.958

2.  A new and simple test for hyperthyroidism employing L-triiodothyronine and the twenty-four hour I-131 uptake method.

Authors:  S C WERNER; M SPOONER
Journal:  Bull N Y Acad Med       Date:  1955-02

3.  Thyroidal suppression by triiodothyronine as a guide to duration of treatment of thyrotoxicosis with antithyroid drugs.

Authors:  W D Alexander; R M Harden; J Shimmins
Journal:  Lancet       Date:  1966-11-12       Impact factor: 79.321

4.  Emotion and non-specific infection as possible aetiological factors in Graves' disease. Their relation to thyroid suppressibility.

Authors:  W D Alexander; R M Harden; J Shimmins
Journal:  Lancet       Date:  1968-07-27       Impact factor: 79.321

5.  Comparison of the thyroid-stimulating hormone content of serum from thyrotoxic and euthyroid people.

Authors:  D D Adams; T H Kennedy; H D Purves
Journal:  J Clin Endocrinol Metab       Date:  1969-07       Impact factor: 5.958
  5 in total
  1 in total

1.  Response to TRH, serum thyroid hormone concentration, and serum markers of autoimmunity after antithyroid therapy in Graves' disease.

Authors:  B A Lamberg; A Aro; P Saarinen; T Tötterman; T Mäkinen
Journal:  J Endocrinol Invest       Date:  1978-01       Impact factor: 4.256
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.